综述

多肽配体技术在植物功能基因组学中的应用前景

展开
  • 中国科学院植物研究所, 系统与进化植物学国家重点实验室, 北京100093

收稿日期: 2009-10-29

  修回日期: 2009-12-31

  网络出版日期: 2010-05-24

基金资助

国家转基因生物新品种培育科技重大专项(编号:2009ZX08009-011B)资助

Peptide aptamer: a powerful potential tool in plant functional genomics

Expand
  • State Key Laboratory of Systematic and Evolutionary Botany, Institute of Botany, Chinese Academy of Sciences, Beijing 100093, China

Received date: 2009-10-29

  Revised date: 2009-12-31

  Online published: 2010-05-24

摘要

人工智能配体或适配体(Aptamer)技术是近年来兴起的一项特异性极强的基因干扰技术。通过人工合成特异的智能配体结合靶基因的蛋白产物, 达到特异干扰靶基因的生物学功能, 这是人工智能配体技术的基本设想。文章综述了多肽配体(Peptide aptamer)技术在基因功能验证中的主要进展, 着重阐明它在植物基因功能验证和作物抗病毒育种中的应用前景, 并提出克服该技术主要风险对策。

本文引用格式

公丕昌,王丽,贺超英 . 多肽配体技术在植物功能基因组学中的应用前景[J]. 遗传, 2010 , 32(6) : 548 -554 . DOI: 10.3724/SP.J.1005.2010.00548

Abstract

Aptamer is a newly invented tool for gene interference in vivo with highly specificity. An aptamer is designed to specifically target a protein and inhibit its biochemical roles for ascertaining its biological functions. Here, we briefly review the major progress of peptide aptamer in validating gene function, and emphasize its promising application in both plant functional genomics and peptide-mediated broad-spectrum plant resistance to diverse phytoviruses. The strategies to overcome the potential risks are covered as well.

参考文献

[1] Ashikari M, Sakakibara H, Lin S, Yamamoto T, Takashi T, Nishimura A, Angeles ER, Qian Q, Kitano H, Matsuoka M. Cytokinin oxidase regulates rice grain production. Science, 2005, 309(5735): 741–745.

[2] Li X, Qian Q, Fu Z, Wang Y, Xiong G, Zeng D, Wang X, Liu X, Teng S, Hiroshi F, Yuan M, Luo D, Han B, Li J. Control of tillering in rice. Nature, 2003, 422(6932): 618–621.

[3] Song XJ, Huang W, Shi M, Zhu M.Z, Lin HX. A QTL for rice grain width and weight encodes a previously unknown RING-type E3 ubiquitin ligase. Nat Genet, 2007, 39(5): 623–630.

[4] Zhang J, Zheng N, Zhou P. Exploring the functional com-plexity of cellular proteins by protein knockout. Proc Natl Acad Sci USA, 2003, 100 (24): 14127–14132.

[5] Stockwell BR. Chemical genetics: ligand-based discovery of gene function. Nat Rev Genet, 2000, 1(2): 116–125.

[6] Ellington AD, Szostak JW. In vitro selection of RNA molecules that bind specific ligands. Nature, 1990, 346 (6287): 818–822.

[7] Bock LC, Griffin LC, Latham JA, Vermaas EH, Toole JJ. Selection of single-stranded DNA molecules that bind and in-hibit human thrombin. Nature, 1992, 355 (6360): 564–566.

[8] Binkowski BF, Miller RA, Belshaw PJ. Ligand-regulated peptides: a general approach for modulating protein-pe- ptide interactions with small molecules. Chem Biol, 2005, 12 (7): 847–855.

[9] Baines I, Colas P. Peptide aptamers as guides for small-molecule drug discovery. Drug Discov Today, 2006, 11(7/8): 334–341.

[10] Hoppe-Seyler F, Crnkovic-Mertens I, Tomai E, Butz K. Peptide aptamers: specific inhibitors of protein function. Curr Mol Med, 2004, 4(5): 529–538.

[11] Hoppe-Seyler F, Butz K. Peptide aptamers: powerful new tools for molecular medicine. J Mol Med, 2000, 78(8): 426–430.

[12] James W. Nucleic acid and polypeptide aptamers: a pow-erful approach to ligand discovery. Curr Opin Pharmacol, 2001, 1(5): 540–546.

[13] Sullenger BA, Gilboa E. Emerging clinical applications of RNA. Nature, 2002, 418 (6894): 252–258.

[14] Ng EW, Shima DT, Calias P, Cunningham ET, Guyer DR, Adamis AP. Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease. Nat Rev Drug Discov, 2006, 5(2): 123–132.

[15] Colas P, Cohen B, Jessen T, Grishina I, McCoy J, Brent R. Genetic selection of peptide aptamers that recognize and inhibit cyclin-dependent kinase 2. Nature, 1996, 380 (6574): 548–550.

[16] Geyer CR, Colman-Lerner A, Brent R. “Mutagenesis” by peptide aptamers identifies genetic network members and pathway connections. Proc Natl Acad Sci USA, 1999, 96(15): 8567–8572.

[17] Norman TC, Smith DL, Sorger PK, IMG SRC, O’Rourke SM, Hughes TR, Roberts CJ, Friend SH, Fields S, Murray AW. Genetic selection of peptide inhibitors of biological pathways. Science, 1999, 285(5427): 591–595.

[18] Tomai E, Butz K, Lohrey C, von Weizsacker F, Zentgraf H, Hoppe-Seyler F. Peptide aptamer-mediated inhibition of target proteins by sequestration into aggresomes. J Biol Chem, 2006, 281(30): 21345–21352.

[19] Kolonin MG, Finley RL. Targeting cyclin-dependent kinases in Drosophila with peptide aptamers. Proc Natl Acad Sci USA, 1998, 95(24): 14266–14271.

[20] Blum JH, Dove SL, Hochschild A, Mekalanos JJ. Isolation of peptide aptamers that inhibit intracellular processes. Proc Natl Acad Sci USA, 2000, 97(5): 2241–2246.

[21] Lopez-Ochoa L, Ramirez-Prado J, Hanley-Bowdoin L. Peptide aptamers that bind to a geminivirus replication protein interfere with viral replication in plant cells. J Virol, 2006, 80(12): 5841–5853.

[22] Lopez-Ochoa L, Hanley-Bowdoin L

文章导航

/